11.68
Sanuwave Health Inc stock is traded at $11.68, with a volume of 96,626.
It is down -3.43% in the last 24 hours and down -18.78% over the past month.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
See More
Previous Close:
$12.10
Open:
$12.1
24h Volume:
96,626
Relative Volume:
0.68
Market Cap:
$100.44M
Revenue:
$44.33M
Net Income/Loss:
$16.05M
P/E Ratio:
35.73
EPS:
0.3269
Net Cash Flow:
$3.85M
1W Performance:
+9.88%
1M Performance:
-18.78%
6M Performance:
-62.30%
1Y Performance:
-67.49%
Sanuwave Health Inc Stock (SNWV) Company Profile
Name
Sanuwave Health Inc
Sector
Industry
Phone
952-656-1029
Address
9600 W. 6TH SSTREET, EDEN PRAIRIE
Compare SNWV vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SNWV
Sanuwave Health Inc
|
29.00 | 34.02M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.50 | 3.32B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.04 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.26 | 327.48M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
4.45 | 292.26M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
47.47 | 0 | 0 | 0 | 0 | 0.00 |
Sanuwave Health Inc Stock (SNWV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Northland Capital | Outperform |
| Jul-29-25 | Initiated | Roth Capital | Buy |
Sanuwave Health Inc Stock (SNWV) Latest News
A Look at SANUWAVE Health Inc (SNWV) After 3.4% Decline -- GF Va - GuruFocus
SANUWAVE Health (SNWV) director granted 5,524 fully vested stock options - Stock Titan
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2000 Dynamic Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000E Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell Small Cap Completeness Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 2500 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM: SNWV) dropped from Russell 3000 Index - marketscreener.com
SANUWAVE Health, Inc.(NasdaqGM:SNWV) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Sanuwave Health, Inc. Actuals & Estimates (NASDAQ:SNWV) - TradingView
SNWV Q1 2026 Earnings: Larger-Than-Expected Loss as Revenue Remains UndisclosedProfit Margin Analysis - dars.gov.et
SNWV: UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts - TradingView
Sanuwave Health eyes revenue up to USD 9.5M in Q2 2026 - Medical Buyer
Sanuwave Health expects Q2 revenue of $8.5M-$9.5M - scanx.trade
Top Midday Decliners - Moomoo
Sanuwave cuts Q2 revenue guidance on weak equipment sales By Investing.com - Investing.com South Africa
Sanuwave Health, Inc. Updates Earnings guidance for the Second Quarter 2026 - marketscreener.com
Sanuwave Health Cuts Q2 Revenue Guidance Amid Market Pressures - TipRanks
Sanuwave cuts Q2 revenue guidance on weak equipment sales - Investing.com
Sanuwave Health Updates Second Quarter 2026 Guidance - The Manila Times
Sanuwave updates Q2 revenue guidance to $8.5–$9.5M, applicator demand strong despite Ultramist headwinds - TradingView
Press Release: Sanuwave Health Updates Second Quarter 2026 Guidance - Moomoo
Sanuwave Health shareholders elect directors and approve auditor at annual meeting - Investing.com
Sanuwave Health Stockholders Approve Directors and Governance Matters - TipRanks
SANUWAVE Health (SNWV) Retreats From Resistance, Testing Key Support LevelsLast Point Support - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Stock RallyRevenue Warning Signal - newsline.com
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider LossROE Trend Analysis - newsline.com
SNWV: Director elections, auditor ratification, and executive pay were voted on; results pending - TradingView
SANUWAVE Health Inc Annual Shareholders Meeting Transcript - GuruFocus
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Commercialization PhaseConsensus Miss Rate - newsline.com
SANUWAVE Health (SNWV) Edges Lower Amid Consolidation Near ResistancePut Flow Alert - dars.gov.et
Sanuwave (SNWV) Q4 2025 Earnings Transcript - The Globe and Mail
SANUWAVE Reports Record Q4 Revenue and Surging System Sales - HarianBasis.co
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock DeclinesAnalyst Consensus Shift - newsline.com
SANUWAVE Health (SNWV) Slips 1.14% as Stock Tests Support Near $15.65Cash Secured Put - newsline.com
SANUWAVE Health Inc. (SNWV) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Company Faces ChallengesEarnings Per Share - dars.gov.et
SANUWAVE Health (SNWV) Shows Strength: Shares Gain Over 4% Amid Bullish Technical SetupMAMA Signal - The Legal Advocate
SNWVSanuwave Health Inc Stock Price and Quote - Finviz
SNWV Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesRevenue Guidance Update - newsline.com
SANUWAVE Health Inc. Q1 2026 Earnings: Significant EPS Miss Leads to Stock DeclineAI Trading Community - Newser
SANUWAVE Health Q1 2026 Earnings: EPS Misses Estimates by 283.8%, Revenue Not Disclosed - Newser
SANUWAVE Health (SNWV) Slips as Stock Tests Key Support Levels Near $16Ascending Triangle - thelegaladvocate.com
SANUWAVE Health Inc. (SNWV) Slips 1.82% as Stock Nears Key Support ZoneChange of Character - Newser
Shareholders Shouldn’t Be Too Comfortable With SANUWAVE Health's (NASDAQ:SNWV) Strong Earnings - Sahm
SANUWAVE Health (SNWV) Q1 2026 Results Miss Estimates — EPS $-0.18 vs $-0.05Debt/EBITDA - Newser
Number of shareholders of SANUWAVE Health, Inc. – NASDAQ:SNWV - TradingView
Sanuwave forecasts Q2 revenue of $11.1M-$11.6M while maintaining $51M-$55M full-year outlook - MSN
Is SANUWAVE Health (SNWV) 212.1% Overvalued After Q1 2026 EPS -$ - GuruFocus
Sanuwave Health Reports Record Q1 2026 Revenue of $9.6 Million - HarianBasis.co
SANUWAVE Health Reports Record Revenue for First Quarter 2026 - HarianBasis.co
SANUWAVE Health Inc (SNWV) Q1 2026 Earnings Call Highlights: Rec - GuruFocus
SANUWAVE Health Balances Growth, Margin Pressure in Q1 - TipRanks
Sanuwave Health Inc Stock (SNWV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):